This article provides a comprehensive guide for researchers, scientists, and drug development professionals on selecting optimal fluorophores for Receptor Occupancy (RO) assays, with a focus on challenging low-expression targets.
This article provides a comprehensive guide for researchers and drug development professionals on Quantitative Structure-Activity Relationship (QSAR) models designed to predict chemical-assay interference.
This article provides a comprehensive overview of Quantitative Structure-Activity Relationship (QSAR) and Quantitative Structure-Property Relationship (QSPR) models as critical tools for predicting the pharmacokinetic (ADME) profiles of drug candidates.
This comprehensive guide explores the foundational principles, methodological application, common pitfalls, and contemporary validation frameworks of the Prentice criteria for surrogate biomarker validation.
This article provides a comprehensive comparison of two key techniques for assessing antibody non-specific interactions (NSI): the dual-membrane Octet®/Biacore-based PSP (Positive-Surface-Potential) assay and the high-throughput CS-SINS (Cross-Interaction Surface Plasmon Resonance...
This article provides a comprehensive guide to Pharmacokinetic/Pharmacodynamic (PK/PD) study design for researchers and drug development professionals.
This comprehensive guide explores the critical role of Pharmacokinetic/Pharmacodynamic (PK/PD) modeling in accelerating and de-risking drug development.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on the critical role of Pharmacokinetic/Pharmacodynamic (PK/PD) modeling in the validation of pharmacodynamic (PD) biomarkers.
This article provides a detailed exploration of the PI3K/Akt signaling pathway as a central regulator of cell survival and apoptosis inhibition, crucial for cancer biology and targeted therapy.
This article provides a comprehensive review for researchers and drug development professionals on the critical challenge of using positron emission tomography (PET) with radiolabeled antibodies for central nervous system targets.